Parexel International, a global biopharmaceutical services provider, announced that the CEO Roundtable on Cancer has again named Parexel a CEO Cancer Gold Standard employer. The biennial U.S.-based accreditation, which Parexel previously received in 2015, recognizes the Company’s strong commitment to the health of its employees and their families.
The Gold Standard provides a framework for employers to have healthier workplaces by focusing on cancer risk education, early detection, access to clinical trials and high-quality care. To earn the accreditation, companies must demonstrate concrete efforts to address cancer in the workplace. Parexel has several programs in place to help its employees reduce cancer risk, including:
“At Parexel, our employees are the key to our success as we help our clients bring life-saving treatments to patients around the globe,” said Josef von Rickenbach, chairman and CEO, Parexel. “We are honored that the CEO Roundtable on Cancer has once again named us a Gold Standard employer for our continued commitment to the health and well-being of our employees and their families.”
The CEO Roundtable on Cancer is a nonprofit organization of CEOs founded in 2001, when former President George H.W. Bush challenged a group of executives to "do something bold and venturesome about cancer within your own corporate families." The CEOs responded by creating and encouraging the widespread adoption of the CEO Cancer Gold Standard™, which calls for organizations to evaluate their health benefits and workplace culture and take extensive, concrete actions in five key areas of health and wellness to address cancer in the workplace.